Question

A 64-year-old male with heart failure with reduced ejection fraction (HFrEF) is on an ACE inhibitor and a beta-blocker. His symptoms remain poorly controlled. Which additional therapy is recommended by NICE to reduce mortality in HFrEF?

Accepted Answer

Mineralocorticoid receptor antagonist (e.g., spironolactone)

Answer

Dihydropyridine calcium-channel blocker

Answer

Loop diuretic

Answer

Ivabradine as first add-on

Answer

None, he is already on optimal therapy

Practice question

A 64-year-old male with heart failure with reduced ejection fraction (HFrEF) is on an ACE inhibitor and a beta-blocker. His symptoms remain poorly controlled. Which additional therapy is recommended by NICE to reduce mortality in HFrEF?